Xilio Therapeutics (XLO) insider trading activity: Get Latest News Today

XLO Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares1.24

Short Percent Of Float1.46

Shares Outstanding51.77M

Shares Float22.00M

Shares Short644.53K

Short Ratio1.43

1.46%

Short % of Float

1.24%

Short % of Shares Outstanding

Market Insider XLO

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

28.17% Percentage of Shares held by All Insiders

47.01% Percentage of Shares held by All Institutions

65.44% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 47.01% of XLO shares are held by financial institutions. OCTAGON CAPITAL ADVISORS LP is the top corporate investor, holding 0 shares valued at -. A 0% stake in Xilio Therapeutics, Inc. is owned by the company. SUMMIT TRAIL ADVISORS, LLC owns 16K shares valued at $17.28K, which translates its holding of 0.06% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Mar 31, 2024	OCTAGON CAPITAL ADVISORS LP	0%	0	-	-1.79M	-100.00%
Mar 31, 2024	SUMMIT TRAIL ADVISORS, LLC	0.06%	16K	17.28K	16K	+100.00%
Mar 31, 2024	FMR LLC	6.92%	1.91M	2.06M	0	0
Mar 31, 2024	RIVERVEST VENTURE MANAGEMENT LLC	5.23%	1.44M	1.56M	0	0
Mar 31, 2024	ROCK SPRINGS CAPITAL MANAGEMENT LP	5.23%	1.44M	1.56M	0	0
Mar 31, 2024	ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC	3.6%	992.91K	1.07M	-1.77M	-64.02%
Mar 31, 2024	VANGUARD GROUP INC	3.28%	902.53K	974.73K	0	0
Mar 31, 2024	BALYASNY ASSET MANAGEMENT L.P.	1.23%	338.54K	365.63K	338.54K	+100.00%
Mar 31, 2024	UBS GROUP AG	0%	201	217	0	0
Mar 31, 2024	ARTAL GROUP S.A.	0%	0	-	-450K	-100.00%
Mar 31, 2024	LAURION CAPITAL MANAGEMENT LP	0%	0	-	-116.85K	-100.00%
Mar 31, 2024	RENAISSANCE TECHNOLOGIES LLC	0.91%	249.45K	269K	39.75K	+18.95%
Mar 31, 2024	MORGAN STANLEY	0.81%	221.91K	239.66K	94.64K	+74.36%
Mar 31, 2024	FIL LTD	0.79%	218.71K	236.2K	0	0
Mar 31, 2024	GEODE CAPITAL MANAGEMENT, LLC	0.31%	84.83K	91.65K	0	0
Mar 31, 2024	BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.26%	71.08K	76.77K	-84.4K	-54.28%
Mar 31, 2024	MILLENNIUM MANAGEMENT LLC	0.25%	70.2K	75.81K	39.85K	+131.29%
Mar 31, 2024	BLACKROCK INC.	0.16%	45.36K	48.98K	-1.51K	-3.22%
Mar 31, 2024	SEVENBRIDGE FINANCIAL GROUP, LLC	0.11%	31K	36.58K	31K	+100.00%
Mar 31, 2024	PFG INVESTMENTS, LLC	0.11%	30K	32.4K	30K	+100.00%
Mar 31, 2024	PRELUDE CAPITAL MANAGEMENT, LLC	0.11%	29.5K	31.86K	29.5K	+100.00%
Mar 31, 2024	FNY INVESTMENT ADVISERS, LLC	0.1%	27.5K	29K	27.5K	+100.00%
Mar 31, 2024	NORTHERN TRUST CORP	0.06%	17.8K	19.22K	0	0
Mar 31, 2024	STATE STREET CORP	0.06%	15.69K	16.95K	0	0
Mar 31, 2024	CHARLES SCHWAB INVESTMENT MANAGEMENT INC	0.04%	11.93K	12.88K	0	0
Mar 31, 2024	TOWER RESEARCH CAPITAL LLC (TRC)	0.04%	11.15K	12.05K	-2.82K	-20.19%
Mar 31, 2024	DUNHILL FINANCIAL, LLC	0.04%	10.27K	15.72K	0	0
Mar 31, 2024	JPMORGAN CHASE & CO	0.01%	2.74K	2.96K	-113	-3.96%
Mar 31, 2024	KEY FINANCIAL INC	0%	830	896	0	0
Mar 31, 2024	ROYAL BANK OF CANADA	0%	533	1K	533	+100.00%
Mar 31, 2024	WELLS FARGO & COMPANY/MN	0%	108	117	2	+1.89%
Mar 31, 2024	QUBE RESEARCH & TECHNOLOGIES LTD	0%	4	4	0	0
Mar 31, 2024	CULLEN/FROST BANKERS, INC.	0%	0	-	-100	-100.00%
Mar 31, 2024	BANK OF AMERICA CORP /DE/	0%	0	-	-11	-100.00%
Mar 31, 2024	CITADEL ADVISORS LLC	0%	0	-	-51.42K	-100.00%
Mar 31, 2024	ARROWMARK COLORADO HOLDINGS LLC	0%	0	-	-83.37K	-100.00%
Mar 31, 2024	VIRTU FINANCIAL LLC	0%	0	-	-10.76K	-100.00%
Mar 31, 2024	BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC	10.18%	2.81M	3.03M	0	0
Dec 31, 2023	ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC	10.03%	2.76M	1.52M	0	0
Dec 31, 2023	FMR LLC	6.93%	1.91M	1.05M	0	0
Dec 31, 2023	OCTAGON CAPITAL ADVISORS LP	6.49%	1.79M	981.75K	-533.5K	-23.01%
Dec 31, 2023	RIVERVEST VENTURE MANAGEMENT LLC	5.24%	1.44M	792.79K	0	0
Dec 31, 2023	ROCK SPRINGS CAPITAL MANAGEMENT LP	5.23%	1.44M	792.42K	0	0
Dec 31, 2023	VANGUARD GROUP INC	3.28%	902.53K	496.39K	12.18K	+1.37%
Dec 31, 2023	ARTAL GROUP S.A.	1.63%	450K	248K	0	0
Dec 31, 2023	TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK	0.91%	249.64K	137.3K	0	0
Dec 31, 2023	FIL LTD	0.79%	218.71K	120.29K	0	0
Dec 31, 2023	RENAISSANCE TECHNOLOGIES LLC	0.76%	209.7K	115K	189K	+913.04%
Dec 31, 2023	BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.56%	155.48K	85.52K	45K	+40.73%
Dec 31, 2023	MORGAN STANLEY	0.46%	127.27K	70K	101K	+384.54%
Dec 31, 2023	LAURION CAPITAL MANAGEMENT LP	0.42%	116.85K	64.27K	-22.41K	-16.09%
Dec 31, 2023	GEODE CAPITAL MANAGEMENT, LLC	0.31%	84.83K	46.67K	0	0
Dec 31, 2023	ARROWMARK COLORADO HOLDINGS LLC	0.3%	83.37K	45.86K	83.37K	+100.00%
Dec 31, 2023	CITADEL ADVISORS LLC	0.19%	51.42K	28.28K	51.42K	+100.00%
Dec 31, 2023	BLACKROCK INC.	0.17%	46.86K	25.77K	-522	-1.10%
Dec 31, 2023	MILLENNIUM MANAGEMENT LLC	0.11%	30.35K	16.69K	30.35K	+100.00%
Dec 31, 2023	NORTHERN TRUST CORP	0.06%	17.8K	9.79K	0	0
Dec 31, 2023	STATE STREET CORP	0.06%	15.69K	8.63K	0	0
Dec 31, 2023	TOWER RESEARCH CAPITAL LLC (TRC)	0.05%	13.98K	7.69K	10.09K	+259.99%
Dec 31, 2023	CHARLES SCHWAB INVESTMENT MANAGEMENT INC	0.04%	11.93K	6.56K	0	0
Dec 31, 2023	VIRTU FINANCIAL LLC	0.04%	10.76K	6K	10.76K	+100.00%
Dec 31, 2023		0.04%	10.27K	5.65K	10.27K	+100.00%
Dec 31, 2023	JPMORGAN CHASE & CO	0.01%	2.86K	1.57K	135	+4.96%
Dec 31, 2023	KEY FINANCIAL INC	0%	830	456	0	0
Dec 31, 2023	UBS GROUP AG	0%	201	111	0	0
Dec 31, 2023	WELLS FARGO & COMPANY/MN	0%	106	58	6	+6.00%
Dec 31, 2023	CULLEN/FROST BANKERS, INC.	0%	100	55	0	0
Dec 31, 2023	BANK OF AMERICA CORP /DE/	0%	11	6	-226.71K	-100.00%
Dec 31, 2023	QUBE RESEARCH & TECHNOLOGIES LTD	0%	4	2	0	0
Dec 31, 2023	DIMENSIONAL FUND ADVISORS LP	0%	0	-	-26.45K	-100.00%
Dec 31, 2023	ROYAL BANK OF CANADA	0%	0	-	-350	-100.00%
Dec 31, 2023	HARVARD MANAGEMENT CO INC	0%	0	-	-416.06K	-100.00%
Dec 31, 2023	SOLEUS CAPITAL MANAGEMENT, L.P.	0%	0	-	-226.94K	-100.00%
Dec 31, 2023	BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC	10.19%	2.81M	1.54M	0	0

XLO Insiders

Among the XLO insiders holding of 28.17% of the stake in company, GILEAD SCIENCES, INC., 10 percent owner, holds the largest shares of 9.11M. BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC, 10 percent owner, is the second largest XLO insider with ownership of 2.8M shares. SV7 IMPACT MEDICINE FUND LP, 10 percent owner, stands third with possession of 1.61M shares of that stake.

Insiders	Designation	Shares Held
GILEAD SCIENCES, INC.	10 percent owner	9.11M
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC	10 percent owner	2.8M
SV7 IMPACT MEDICINE FUND LP	10 percent owner	1.61M
RIVERVEST VENTURE FUND IV, L.P.	10 percent owner	1.44M
ROCK SPRINGS CAPITAL MANAGEMENT LP	10 percent owner	1.26M
FLYNN JAMES E	10 percent owner	1.14M
BAY CITY CAPITAL LLC	10 percent owner	1.13M
ATLAS VENTURE FUND XI, L.P.	10 percent owner	734.55K
FRANKENFIELD CHRISTOPHER JAMES	Chief Financial Officer	12.42K
BRENNAN KEVIN M.	SVP, FINANCE AND ACCOUNTING	3.2K

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Jan 02, 2025	FRANKENFIELD CHRISTOPHER JAMES	SALE	0.98	6.95K	6.84K	12.42K
Jan 02, 2025	BRENNAN KEVIN M.	SALE	0.98	1.8K	1.77K	3.2K
Dec 18, 2024	GILEAD SCIENCES, INC.	PURCHASE	1.04	1.76M	1.83M	9.11M
Apr 02, 2024	GILEAD SCIENCES, INC.	PURCHASE	0.00	3.88M	388.25	3.88M
Feb 08, 2024	ATLAS VENTURE FUND XI, L.P.	SALE	0.64	267	170.88	734.55K
Jan 12, 2024	ATLAS VENTURE FUND XI, L.P.	SALE	0.83	560	464.8	734.81K
Jan 11, 2024	ATLAS VENTURE FUND XI, L.P.	SALE	0.87	569	495.03	735.37K
Dec 10, 2021	BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC	PURCHASE	9.56	21.81K	208.56K	2.8M
Dec 09, 2021	BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC	PURCHASE	9.84	4.01K	39.49K	2.78M
Dec 08, 2021	BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC	PURCHASE	9.62	13.46K	129.47K	2.78M
Oct 26, 2021	ROCK SPRINGS CAPITAL MANAGEMENT LP	PURCHASE	16.00	500K	8M	1.26M
Oct 26, 2021	ATLAS VENTURE FUND XI, L.P.	PURCHASE	16.00	187.5K	3M	735.94K
Oct 26, 2021	SV7 IMPACT MEDICINE FUND LP	PURCHASE	16.00	312.5K	5M	1.61M
Oct 26, 2021	FLYNN JAMES E	PURCHASE	16.00	387.5K	6.2M	1.14M
Oct 26, 2021	RIVERVEST VENTURE FUND IV, L.P.	PURCHASE	16.00	250K	4M	1.44M
Oct 26, 2021	BAY CITY CAPITAL LLC	PURCHASE	16.00	312.5K	5M	1.13M

Insider Transaction Summary (6 Months)

SHARESTRANS

PURCHASE1.76M1

SALES8.76K2

NET SHARES1.75M1

SHARES HELD9.12M3

% NET SHARES-80.8%-66.67%

XLO Stock Ownership Breakdown

Xilio Therapeutics, Inc.

XLO Stock Outstanding Shares

Market Insider XLO

Institutional Ownership

XLO Insiders

Buying/Selling by Insiders

Insider Transaction Summary (6 Months)

Frequently Asked Questions

XLO Stock Outstanding Shares

Market Insider XLO

Institutional Ownership

XLO Insiders

Buying/Selling by Insiders

Insider Transaction Summary (6 Months)

Frequently Asked Questions